Skip to Content
Contact Form Map & Directions Videos

Category: Articles

Rushed Pharma Leads to Bad Karma — The Tale of Pradaxa


Pradaxa (dabigatran etexilate mesylate), a new oral anticoagulant, achieved Food & Drug Administration (“FDA”) approval on October 19, 2010. One notable advantage of using Pradaxa to replace Warfarin to prevent clot formation is the elimination of INR testing in patients taking Pradaxa. INR is the acronym for International Normalized Ratio, which is used to monitor the effectiveness of anticoagulant such as warfarin.

Read More

Hear What Our Clients Have To Say

"Amazing law firm! As an attorney myself I can say that they truly care about their clients and it shows!"
Posted By: Clinton Cimring